The design of this Japanese vendor's new x-ray angiography systemhas been raising eyebrows since it was featured in a panel displayin the company's booth at the 1994 RSNA meeting. SF-VA 100 isa rotational angiography system, but it looks more like a CT
The design of this Japanese vendor's new x-ray angiography systemhas been raising eyebrows since it was featured in a panel displayin the company's booth at the 1994 RSNA meeting. SF-VA 100 isa rotational angiography system, but it looks more like a CT scanner,due to the gantry that houses the system's x-ray tube and assembly.
Hitachi will finally be able to test the commercial watersfor SF-VA 100 after receiving 510(k) clearance for the productthis summer. SF-VA 100 generates up to 288 views acquired in a360° rotation performed in five seconds. The digitized sequencemay be played back in subtracted or nonsubtracted modes to createa detailed 360° perspective of selected vasculature and surroundingstructures.
In MRI, enhancements for the open-style Airis and 1.5-teslaStratis will be the promotional focal points for Hitachi. Thecompany will highlight version 4.0 software for the 0.3-teslaAiris, which features image display and control panel refinements,improved fast spin-echo imaging, and fast fluid-attenuated inversionrecovery (Fast Flair), a sequence for fluid-suppressed T2-weightedimaging. The Stratis presentation will feature phased-array coilsand echo-planar imaging, according to Sheldon Schaffer, directorof marketing.
The ultrasound section of Hitachi's booth will feature EUB-525,a color-flow scanner. The system has been displayed at previousRSNA meetings, but Hitachi began shipments in August after receivingFDA clearance, according to Patrick Herguth, product manager forthe ultrasound division.
GE HealthCare Launches AI Mammography Platform with Key Applications from iCAD
November 30th 2023Offering an all-in-one platform of artificial intelligence (AI) applications, MyBreastAI Suite reportedly facilitates early breast cancer detection and enhances efficiency with breast imaging workflows.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.